摘要：Methicillin-resistant Staphylococcus aureus (MRSA) continues to be a major cause of nosocomialinfection in Australia. In Western Australia, a new type of MRSA (WA MRSA) appeared someyears ago and has become endemic in the community. While initially susceptible to mostantibiotics, WA MRSA has begun to acquire additional resistance determinants, includingtrimethoprim and mupirocin resistance, prompting a review of emerging resistance to otherantibiotics. Resistance to sodium fusidate, which remained at around 1 - 2% of isolates for manyyears, rose to 3% in 1993, 5% in 1994 and 9% in 1995. These findings suggest that the use of sodiumfusidate in both hospital and community medicine may require review
